The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Lyra Therapeutics, Inc(NASDAQ:LYRA) 
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's XTreo technology platform is designed to deliver...
Website: http://www.lyratherapeutics.com
Founded: 2005
Full Time Employees: 33
CEO: Maria Palasis
Sector: Healthcare
Industry: Biotechnology
Lyra Therapeutics Number of Twitter Followers
Lyra Therapeutics Days Payable Outstanding ttm (DPO)
Lyra Therapeutics Days Receivable Outstanding ttm (DSO)
Lyra Therapeutics Op Cashflow Per Share ttm
Lyra Therapeutics Free Cashflow Per Share ttm
Lyra Therapeutics Cash Per Share ttm
Lyra Therapeutics P/S ratio ttm
Lyra Therapeutics (GAAP) P/E ratio ttm
Lyra Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.